Elsayes KM, Kielar AZ, Chernyak V, Morshid A, Furlan A, Masch WR, Marks RM, Kamaya A, Do RKG, Kono Y, Fowler KJ, Tang A, Bashir MR, Hecht EM, Jambhekar K, Lyshchik A, Rodgers SK, Heiken JP, Kohli M, Fetzer DT, Wilson SR, Kassam Z, Mendiratta-Lala M, Singal AG, Lim CS, Cruite I, Lee J, Ash R, Mitchell DG, McInnes MDF, Sirlin CB

Journal of Hepatocellular Carcinoma 2019, 6:49-69

Published Date: 5 February 2019

Meeting Report

Road map for fibrolamellar carcinoma: progress and goals of a diversified approach

Kastenhuber ER, Craig J, Ramsey J, Sullivan KM, Sage J, de Oliveira S, Riehle KJ, Scott JD, Gordan JD, Bardeesy N, Abou-Alfa GK

Journal of Hepatocellular Carcinoma 2019, 6:41-48

Published Date: 31 January 2019

Review

Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date

Personeni N, Pressiani T, Rimassa L

Journal of Hepatocellular Carcinoma 2019, 6:31-39

Published Date: 31 January 2019

Review

Weighing the benefits of hepatocellular carcinoma surveillance against potential harms

Geh D, Rana FA, Reeves HL

Journal of Hepatocellular Carcinoma 2019, 6:23-30

Published Date: 14 January 2019

Review

Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions

Stavraka C, Rush H, Ross P

Journal of Hepatocellular Carcinoma 2019, 6:11-21

Published Date: 28 December 2018

Review

Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria

Amado V, Rodríguez-Perálvarez M, Ferrín G, De la Mata M

Journal of Hepatocellular Carcinoma 2019, 6:1-10

Published Date: 21 December 2018

Original Research

Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study)

Azim HA, Omar A, Atef H, Zawahry H, Shaker MK, Abdelmaksoud AHK, EzzElarab M, Abdel-Rahman O, Ismail M, Kassem L, Waked I

Journal of Hepatocellular Carcinoma 2018, 5:109-119

Published Date: 19 November 2018

Review

Hepatocellular carcinoma: a review of diagnostic challenges for the pathologist

Quaglia A

Journal of Hepatocellular Carcinoma 2018, 5:99-108

Published Date: 8 November 2018

Review

Potential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoprotein

Gilabert M, Raoul JL

Journal of Hepatocellular Carcinoma 2018, 5:91-98

Published Date: 2 November 2018

Review

Update on hepatocellular carcinoma from the 2018 Gastrointestinal Cancer Symposium (ASCO GI)

de Jesus VHF, Dettino ALA

Journal of Hepatocellular Carcinoma 2018, 5:87-90

Published Date: 3 October 2018

Original Research

Hepatitis C virus-associated hepatocellular carcinoma as a second primary malignancy: exposing an overlooked presentation of liver cancer

Dandachi D, Hassan M, Kaseb A, Angelidakis G, Torres HA

Journal of Hepatocellular Carcinoma 2018, 5:81-86

Published Date: 2 August 2018

Review

Hepatocellular cancer pain: impact and management challenges

Christian-Miller N, Frenette C

Journal of Hepatocellular Carcinoma 2018, 5:75-80

Published Date: 19 July 2018

Review

Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance

Khalaf AM, Fuentes D, Morshid AI, Burke MR, Kaseb AO, Hassan M, Hazle JD, Elsayes KM

Journal of Hepatocellular Carcinoma 2018, 5:61-73

Published Date: 27 June 2018

Case Series

Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance

Griffith AS, Hayashi PH, Burke LMB, McRee AJ

Journal of Hepatocellular Carcinoma 2018, 5:55-59

Published Date: 31 May 2018

Editorial

Editorial: charting the future of hepatocellular carcinoma publications

Kaseb AO

Journal of Hepatocellular Carcinoma 2018, 5:51-54

Published Date: 8 May 2018

Review

Basic MRI for the liver oncologists and surgeons

Vu LN, Morelli JN, Szklaruk J

Journal of Hepatocellular Carcinoma 2018, 5:37-50

Published Date: 10 April 2018

Clinical Trial Report

Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt

Shaker MK, Montasser IF, Sakr M, Elgharib M, Dabbous HM, Ebada H, El Dorry A, Bahaa M, El Meteini M

Journal of Hepatocellular Carcinoma 2018, 5:29-36

Published Date: 27 February 2018

Review

Pretreatment neutrophil–lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma

Najjar M, Agrawal S, Emond JC, Halazun KJ

Journal of Hepatocellular Carcinoma 2018, 5:17-28

Published Date: 18 January 2018

Original Research

Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma

Feun LG, Wangpaichitr M, Li YY, Kwon D, Richman SP, Hosein PJ, Savaraj N

Journal of Hepatocellular Carcinoma 2018, 5:9-15

Published Date: 12 January 2018

Original Research

Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma

Liang B, Yao SY, Zhou JP, Li ZK, Liu TQ

Journal of Hepatocellular Carcinoma 2018, 5:1-7

Published Date: 12 January 2018

Original Research

Characterization of alpha-fetoprotein effects on dendritic cell and its function as effector immune response activator

Suryatenggara J, Wibowo H, Atmodjo WL, Mathew G

Journal of Hepatocellular Carcinoma 2017, 4:139-151

Published Date: 28 November 2017

Review

Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutions

Ray EM, Sanoff HK

Journal of Hepatocellular Carcinoma 2017, 4:131-138

Published Date: 8 November 2017

Original Research

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma

Fateen W, Khan F, O’Neill RJ, James MW, Ryder SD, Aithal GP

Journal of Hepatocellular Carcinoma 2017, 4:123-130

Published Date: 16 October 2017

Clinical Trial Report

A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect

de la Torre AN, Contractor S, Castaneda I, Cathcart CS, Razdan D, Klyde D, Kisza P, Gonzales SF, Salazar AM

Journal of Hepatocellular Carcinoma 2017, 4:111-121

Published Date: 7 August 2017

Review

Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review

Sacco R, Tapete G, Simonetti N, Sellitri R, Natali V, Melissari S, Cabibbo G, Biscaglia L, Bresci G, Giacomelli L

Journal of Hepatocellular Carcinoma 2017, 4:105-110

Published Date: 27 July 2017

Review

Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies

Galun D, Srdic-Rajic T, Bogdanovic A, Loncar Z, Zuvela M

Journal of Hepatocellular Carcinoma 2017, 4:93-103

Published Date: 11 July 2017

Review

Hepatocellular carcinoma: early-stage management challenges

Erstad DJ, Tanabe KK

Journal of Hepatocellular Carcinoma 2017, 4:81-92

Published Date: 23 June 2017

Review

Screening for hepatocellular carcinoma: patient selection and perspectives

Fateen W, Ryder SD

Journal of Hepatocellular Carcinoma 2017, 4:71-79

Published Date: 17 May 2017

Clinical Trial Report

Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

Tarakanovskaya MG, Chinburen J, Batchuluun P, Munkhzaya C, Purevsuren G, Dandii D, Hulan T, Oyungerel D, Kutsyna GA, Reid AA, Borisova V, Bain AI, Jirathitikal V, Bourinbaiar AS

Journal of Hepatocellular Carcinoma 2017, 4:59-69

Published Date: 12 April 2017

Review

Irreversible electroporation of hepatocellular carcinoma: patient selection and perspectives

Zimmerman A, Grand D, Charpentier KP

Journal of Hepatocellular Carcinoma 2017, 4:49-58

Published Date: 13 March 2017

Case Series

A single institution report of 19 hepatocellular carcinoma patients with bile duct tumor thrombus

Chotirosniramit A, Liwattanakun A, Lapisatepun W, Ko-iam W, Sandhu T, Junrungsee S

Journal of Hepatocellular Carcinoma 2017, 4:41-47

Published Date: 7 March 2017

Expert Opinion

Liver Imaging Reporting and Data System: an expert consensus statement

Elsayes KM, Kielar AZ, Agrons MM, Szklaruk J, Tang A, Bashir MR, Mitchell DG, Do RK, Fowler KJ, Chernyak V, Sirlin CB

Journal of Hepatocellular Carcinoma 2017, 4:29-39

Published Date: 17 February 2017

Review

Needle track seeding after radiofrequency ablation for hepatocellular carcinoma: prevalence, impact, and management challenge

Francica G

Journal of Hepatocellular Carcinoma 2017, 4:23-27

Published Date: 20 January 2017

Review

Pediatric hepatocellular carcinoma: challenges and solutions

Schmid I, von Schweinitz D

Journal of Hepatocellular Carcinoma 2017, 4:15-21

Published Date: 16 January 2017

Commentary

Strengthening the case that elevated levels of programmed death ligand 1 predict poor prognosis in hepatocellular carcinoma patients

Zhong J, Luo C, Zhang C, Li L

Journal of Hepatocellular Carcinoma 2017, 4:11-13

Published Date: 30 December 2016

Review

Surgical resection of localized hepatocellular carcinoma: patient selection and special consideration

Ma KW, Cheung TT

Journal of Hepatocellular Carcinoma 2017, 4:1-9

Published Date: 28 December 2016

Review

Profile of tivantinib and its potential in the treatment of hepatocellular carcinoma: the evidence to date

Pievsky D, Pyrsopoulos N

Journal of Hepatocellular Carcinoma 2016, 3:69-76

Published Date: 15 November 2016

Review

GPC-3 in hepatocellular carcinoma: current perspectives

Wu Y, Liu H, Ding H

Journal of Hepatocellular Carcinoma 2016, 3:63-67

Published Date: 8 November 2016

Review

Minimally invasive image-guided therapies for hepatocellular carcinoma

Abdelsalam ME, Murthy R, Avritscher R, Mahvash A, Wallace MJ, Kaseb AO, Odisio BC

Journal of Hepatocellular Carcinoma 2016, 3:55-61

Published Date: 11 October 2016

Review

Hepatocellular carcinoma: a review

Balogh J, Victor III D, Asham EH, Burroughs SG, Boktour M, Saharia A, Li X, Ghobrial RM, Monsour Jr HP

Journal of Hepatocellular Carcinoma 2016, 3:41-53

Published Date: 5 October 2016

Commentary

Does alpha-fetoprotein contribute to the mortality and morbidity of human hepatocellular carcinoma? A commentary

Mizejewski GJ

Journal of Hepatocellular Carcinoma 2016, 3:37-40

Published Date: 21 September 2016

Review

Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma

Trojan J, Waidmann O

Journal of Hepatocellular Carcinoma 2016, 3:31-36

Published Date: 21 September 2016

Review

Transarterial radioembolization for hepatocellular carcinoma: a review

Sacco R, Conte C, Tumino E, Parisi G, Marceglia S, Metrangolo S, Eggenhoffner R, Bresci G, Cabibbo G, Giacomelli L

Journal of Hepatocellular Carcinoma 2016, 3:25-29

Published Date: 25 July 2016

Original Research

Clinical significance of vascular endothelial growth factor in hepatitis C related hepatocellular carcinoma in Egyptian patients

Atta MM, Atta HM, Gad MA, Rashed LA, Said EM, Hassanien SE, Kaseb AO

Journal of Hepatocellular Carcinoma 2016, 3:19-24

Published Date: 14 June 2016

Review

Hepatocellular carcinoma in elderly patients: challenges and solutions

Brunot A, Le Sourd S, Pracht M, Edeline J

Journal of Hepatocellular Carcinoma 2016, 3:9-18

Published Date: 17 June 2016

Original Research

Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma

Mahvash A, Murthy R, Odisio BC, Raghav KP, Girard L, Cheung S, Nguyen V, Ensor J, Gadani S, Elsayes KM, Abdel-Wahab R, Hassan M, Shalaby AS, Yao JC, Wallace MJ, Kaseb AO

Journal of Hepatocellular Carcinoma 2016, 3:1-7

Published Date: 5 February 2016

Review

Fibrolamellar hepatocellular carcinoma: current clinical perspectives

Lafaro KJ, Pawlik TM

Journal of Hepatocellular Carcinoma 2015, 2:151-157

Published Date: 9 October 2015

Review

Role of endoscopic ultrasound in diagnosis and management of hepatocellular carcinoma

Koduru P, Suzuki R, Lakhtakia S, Ramchandani M, Makmun D, Bhutani MS

Journal of Hepatocellular Carcinoma 2015, 2:143-149

Published Date: 6 October 2015

Review

Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma

Abdel-Wahab R, Shehata S, Hassan MM, Habra MA, Eskandari G, Tinkey PT, Mitchell J, Lee JS, Amin HM, Kaseb AO

Journal of Hepatocellular Carcinoma 2015, 2:131-142

Published Date: 18 September 2015

Review

Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy

Jang JH, Lee JW, Hong JT, Jin YJ

Journal of Hepatocellular Carcinoma 2015, 2:123-129

Published Date: 2 September 2015

Editorial

Whither α-FP in the diagnosis of hepatocellular carcinoma?

Kew MC

Journal of Hepatocellular Carcinoma 2015, 2:119-121

Published Date: 24 August 2015

Review

State-of-the-art cross-sectional liver imaging: beyond lesion detection and characterization

Luersen GF, Bhosale P, Szklaruk J

Journal of Hepatocellular Carcinoma 2015, 2:101-117

Published Date: 10 July 2015

Review

The androgen receptor as an emerging target in hepatocellular carcinoma

Kanda T, Yokosuka O

Journal of Hepatocellular Carcinoma 2015, 2:91-99

Published Date: 26 June 2015

Original Research

Ambovex® as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial

Salama H, Ahmad H, Elchagea I, Zekri AR, Medhat E, Bahnassy A, Lange M, Rabbat M, de la Torre AN, Punamiya P

Journal of Hepatocellular Carcinoma 2015, 2:79-89

Published Date: 22 June 2015

Review

Emerging role of Hpo signaling and YAP in hepatocellular carcinoma

Valero V III, Pawlik TM, Anders RA

Journal of Hepatocellular Carcinoma 2015, 2:69-78

Published Date: 18 June 2015

Original Research

Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral chemoimmunotherapy

Gao F, Jing P, Liu J, Lu YF, Zhang PC, Han W, Liu GL, Ru N, Cui GH, Sun CL, Che YB, Zhang HM, Hu QL, Wang HY, Wu YL, Guan CJ, Fu Q, Ma ZL, Yu BF

Journal of Hepatocellular Carcinoma 2015, 2:57-68

Published Date: 9 June 2015

Editorial

Hepatocellular carcinoma ablation and possible immunity in the age of nanosecond pulsed electric fields

Beebe SJ

Journal of Hepatocellular Carcinoma 2015, 2:49-55

Published Date: 22 May 2015

Original Research

Early α-fetoprotein response predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib

Lee SH, Kim BK, Kim SU, Park JY, Kim DY, Ahn SH, Han KH

Journal of Hepatocellular Carcinoma 2015, 2:39-47

Published Date: 28 April 2015

Review

c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma

Granito A, Guidetti E, Gramantieri L

Journal of Hepatocellular Carcinoma 2015, 2:29-38

Published Date: 24 April 2015

Review

A clinical perspective of the link between metabolic syndrome and hepatocellular carcinoma

Cauchy F, Belghiti J

Journal of Hepatocellular Carcinoma 2015, 2:19-27

Published Date: 23 February 2015

Review

Emerging role of Toll-like receptor 4 in hepatocellular carcinoma

Yang J, Li M, Zheng QC

Journal of Hepatocellular Carcinoma 2015, 2:11-17

Published Date: 16 February 2015

Original Research

Untreated hepatocellular carcinoma in Egypt: outcome and prognostic factors

Zeeneldin AA, Salem SE, Darwish AD, El-Gammal MM, Hussein MM, Saadeldin M

Journal of Hepatocellular Carcinoma 2015, 2:3-9

Published Date: 30 January 2015

Editorial

Welcome to Journal of Hepatocellular Carcinoma

Kaseb AO

Journal of Hepatocellular Carcinoma 2015, 2:1-2

Published Date: 9 January 2015

Original Research

Chemoembolization with drug-eluting microspheres (DEM-TACE) for hepatocellular carcinoma: single-center review of safety and efficacy

Bishay VL, Maglione K, Khanna R, Lee KM, Fischman AM, Lookstein RA, Kim E

Journal of Hepatocellular Carcinoma 2014, 1:187-193

Published Date: 27 November 2014

Review

Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma

Aiolfi R, Sitia G

Journal of Hepatocellular Carcinoma 2014, 1:183-186

Published Date: 13 November 2014

Review

Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments

Cappelli A, Pettinato C, Golfieri R

Journal of Hepatocellular Carcinoma 2014, 1:163-182

Published Date: 3 November 2014

Original Research

Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models

Braidwood L, Learmonth K, Graham A, Conner J

Journal of Hepatocellular Carcinoma 2014, 1:149-161

Published Date: 16 October 2014

Review

Radiological diagnosis of hepatocellular carcinoma

Bargellini I, Battaglia V, Bozzi E, Lauretti DL, Lorenzoni G, Bartolozzi C

Journal of Hepatocellular Carcinoma 2014, 1:137-148

Published Date: 9 September 2014

Review

Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma

Hsu HT, Chi CW

Journal of Hepatocellular Carcinoma 2014, 1:127-135

Published Date: 26 August 2014

Review

Hepatocellular carcinoma: epidemiology and risk factors

Kew MC

Journal of Hepatocellular Carcinoma 2014, 1:115-125

Published Date: 13 August 2014

Case Series

Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series

Torres HA, Kaseb A, Mahale P, Miller E, Frenette C

Journal of Hepatocellular Carcinoma 2014, 1:109-114

Published Date: 16 July 2014

Review

Clinical utility of imaging for evaluation of hepatocellular carcinoma

Murakami T, Tsurusaki M, Hyodo T, Imai Y

Journal of Hepatocellular Carcinoma 2014, 1:101-108

Published Date: 14 July 2014

Review

Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives

Hsu CH, Shen YC, Shao YY, Hsu C, Cheng AL

Journal of Hepatocellular Carcinoma 2014, 1:85-99

Published Date: 12 June 2014

Review

New insights on the role of epigenetic alterations in hepatocellular carcinoma

Frau M, Feo CF, Feo F, Pascale RM

Journal of Hepatocellular Carcinoma 2014, 1:65-83

Published Date: 12 June 2014

Original Research

Potential immunotherapeutic role of interleukin-2 and interleukin-12 combination in patients with hepatocellular carcinoma

Gabeen AA, Abdel-Hamid FF, El-Houseini ME, Fathy SA

Journal of Hepatocellular Carcinoma 2014, 1:55-63

Published Date: 9 June 2014

Review

Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma

Coleman SJ, Grose RP, Kocher HM

Journal of Hepatocellular Carcinoma 2014, 1:43-54

Published Date: 29 May 2014

Review

Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma

Ofuji K, Saito K, Yoshikawa T, Nakatsura T

Journal of Hepatocellular Carcinoma 2014, 1:35-42

Published Date: 21 May 2014

Review

Micro-ribonucleic acids: potential noninvasive biomarkers for hepatocellular carcinoma

Li L, Diao W, Zen K

Journal of Hepatocellular Carcinoma 2014, 1:21-33

Published Date: 21 May 2014

Review

Emerging role of insulin-like growth factor-binding protein 7 in hepatocellular carcinoma

Akiel M, Rajasekaran D, Gredler R, Siddiq A, Srivastava J, Robertson C, Jariwala NH, Fisher PB, Sarkar D

Journal of Hepatocellular Carcinoma 2014, 1:9-19

Published Date: 26 March 2014

Review

A review on the diagnosis and treatment of hepatocellular carcinoma with a focus on the role of Wnts and the dickkopf family of Wnt inhibitors

Shi J, Keller JM, Zhang J, Keller ET

Journal of Hepatocellular Carcinoma 2014, 1:1-7

Published Date: 6 March 2014